Skip to content ↓

IS&T recommends Mac users wait before upgrading to OS 10.9

Yesterday, Apple released its newest operating system for the Mac, OS X Mavericks (10.9). Based on preliminary testing of prerelease versions of the OS, Information Services and Technology (IS&T) recommends that Mac users wait to upgrade and continue to use Mac OS X 10.7 or 10.8 while IS&T completes its review and testing of OS X Mavericks.

Why wait?

The recommendation to wait is based on two key concerns:
  • Crucial and high-use applications need to be tested in the MIT environment.
  • Vendor certification of applications under OS X Mavericks is also important.
Testing thus far has not shown any major problems with current versions of software, but until we are able to confirm these results on the final release and with our vendors, the MIT community should wait. Departmental users should also check with their local IT support about rollout plans.

For more information or questions about the release process, contact the Software Release Team at swrt@mit.edu.

Limited Support

The IS&T Computing Help Desk is offering limited support for early adopters of OS X Mavericks (10.9) and for those with new machines that have OS X Mavericks preinstalled. Limited support at this time includes:
  • Getting connected to the MIT network
  • Setting up Mail, Calendars, and Contacts with MIT's Exchange environment.
As critical application testing is completed and vendor certification is announced, IS&T will provide more in-depth support.

Help documentation for OS X Mavericks (10.9) can be found in the Knowledge Base. This page will be updated frequently.

For questions or assistance with OS X Mavericks, contact the Help Desk at 617.253.1101 or helpdesk@mit.edu. You can also submit a request online.

Related Links

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story